Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 259

    1.

    Lowering of serum cholesterol and triglyceride by para-aminosalicylic acid in hyperlipoproteinemia. Studies in patients with types II-A and II-B.

    Barter PJ, Connor WE, Spector AA, Armstrong M, Connor SL, Newman MA.

    Ann Intern Med. 1974 Nov;81(5):619-24. No abstract available. PMID: 4609028 [PubMed - indexed for MEDLINE]Related articles

    2.

    Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.

    Levy RI, Fredrickson DS, Stone NJ, Bilheimer DW, Brown WV, Glueck CJ, Gotto AM, Herbert PN, Kwiterovich PO, Langer T, LaRosa J, Lux SE, Rider AK, Shulman RS, Sloan HR.

    Ann Intern Med. 1973 Jul;79(1):51-8. No abstract available. PMID: 4578640 [PubMed - indexed for MEDLINE]Related articles

    3.

    A long-term study of the efficacy of oxandrolone in hyperlipoproteinemias.

    Malmendier CL, van den Bergen CJ, Emplit G, Delcroix C.

    J Clin Pharmacol. 1978 Jan;18(1):42-53.PMID: 338645 [PubMed - indexed for MEDLINE]Related articles

    5.

    Effect of a single dose of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia.

    Carlson LA, Orö L, Ostman J.

    Acta Med Scand. 1968 May;183(5):457-65. No abstract available. PMID: 4883477 [PubMed - indexed for MEDLINE]Related articles

    6.

    Colestipol in familial type II hyperlipoproteinemia: a three-year trial.

    Harvengt C, Desager JP.

    Clin Pharmacol Ther. 1976 Sep;20(3):310-4.PMID: 182429 [PubMed - indexed for MEDLINE]Related articles

    7.

    Type IV hyperlipoproteinemia. Clofibrate without dietary therapy.

    Zelis R, Amsterdam EA, Spann JF Jr, Mason DT.

    JAMA. 1972 Oct 16;222(3):326-8. No abstract available. PMID: 4566727 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions]

    Klemens UH, von Löwis P.

    Dtsch Med Wochenschr. 1973 Jun 15;98(24):1197-202. German. No abstract available. PMID: 4350685 [PubMed - indexed for MEDLINE]Related articles

    9.

    Treatment of type II hyperlipoproteinemia with d-thyroxine.

    Rakow AD, Klor HU, Kuter E, Ditschuneit HH, Ditschuneit H.

    Atherosclerosis. 1976 Sep;24(3):369-80.PMID: 971340 [PubMed - indexed for MEDLINE]Related articles

    10.

    Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.

    Oriente P, Motolese M, Cerqua R, Mancini M.

    Int Z Klin Pharmakol Ther Toxikol. 1969 Oct;2(4):348-53. No abstract available. PMID: 4903988 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment of primary hyperlipoproteinaemias with a tetralin derivative (Su-13'437).

    Fellin R, Fedele D, Bagnariol G, Pagnan A, Crepaldi G.

    Atherosclerosis. 1973 May-Jun;17(3):383-8. No abstract available. PMID: 4577009 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of a new niacin derivative (nicotinic hexaester of D-glucitol) on type IIA, IIB and IV hyperlipoproteinemia in man.

    Avogaro P, Bittolo-Bon G, Pais M, Taroni GC.

    Pharmacol Res Commun. 1977 Jun;9(6):599-606. No abstract available. PMID: 197548 [PubMed - indexed for MEDLINE]Related articles

    13.

    Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.

    Glueck CJ, Ford S Jr, Scheel D, Steiner P.

    JAMA. 1972 Nov 6;222(6):676-81. No abstract available. PMID: 4562098 [PubMed - indexed for MEDLINE]Related articles

    14.

    Familial hypercholesterolemia in children: treatment with p-aminosalicylic acid.

    Malloy MJ, Kane JP, Rowe JS.

    Pediatrics. 1978 Mar;61(3):365-72. No abstract available. PMID: 205828 [PubMed - indexed for MEDLINE]Related articles

    15.

    Inefficiency of cynarin as therapeutic regimen in familial type II hyperlipoproteinaemia.

    Heckers H, Dittmar K, Schmahl FW, Huth K.

    Atherosclerosis. 1977 Feb;26(2):249-53.PMID: 576409 [PubMed - indexed for MEDLINE]Related articles

    17.

    Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia.

    Camarri E, Fici F, Marcolongo R.

    Int J Clin Pharmacol Biopharm. 1978 Nov;16(11):523-6.PMID: 365796 [PubMed - indexed for MEDLINE]Related articles

    18.

    Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.

    Davignon J, Aubry F, Noël C, Lapierre Y, Lafortune M.

    Rev Can Biol. 1971 Dec;30(4):307-18. No abstract available. PMID: 5135408 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types 3, IV, and V familial hyperlipoproteinemia.

    Glueck CJ.

    Metabolism. 1971 Jul;20(7):691-702. No abstract available. PMID: 5090133 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Effect of pangamic acid (Calgam) in type II hyperlipidemia]

    Bogdañska-Czarnyszewicz, Czaplicki S, Michajlik A.

    Pol Tyg Lek. 1972 Dec 18;27(51):2032-5. Polish. No abstract available. PMID: 4653721 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data